Cargando…

Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.

Topoisomerase II is a key target for several anti-cancer drugs used for breast cancer therapy, including doxorubicin, epirubicin and mitoxantrone. Two isoforms of topoisomerase II (alpha and beta) have been described in human cells which differ in their subcellular localisation, biochemical properti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandri, M. I., Hochhauser, D., Ayton, P., Camplejohn, R. C., Whitehouse, R., Turley, H., Gatter, K., Hickson, I. D., Harris, A. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074549/ https://www.ncbi.nlm.nih.gov/pubmed/8664122

Ejemplares similares

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues.
por: Turley, H., et al.
Publicado: (1997)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.
por: Houlbrook, S., et al.
Publicado: (1995)

Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.
por: Coutts, J., et al.
Publicado: (1993)

The Significance of Topoisomerase II Alpha in Invasive Breast Carcinoma
por: Arthi, M, et al.
Publicado: (2021)

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a(-/- )mutants
por: Sapetto-Rebow, Beata, et al.
Publicado: (2011)

Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors.
por: Davies, S. L., et al.
Publicado: (1997)

The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells
por: Turley, H, et al.
Publicado: (2001)

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
por: An, Xin, et al.
Publicado: (2018)

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
por: Fox, S. B., et al.
Publicado: (1996)

Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders
por: Uusküla-Reimand, Liis, et al.
Publicado: (2016)

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors
por: Sato, K, et al.
Publicado: (2003)

Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin
por: Siriwardana, Pulathis N., et al.
Publicado: (2016)

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
por: Withoff, S., et al.
Publicado: (1996)

Regulation of the catalytic function of topoisomerase II alpha through association with RNA
por: Park, Seung-Won, et al.
Publicado: (2008)

Cell Cycle–coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities
por: Meyer, Kay N., et al.
Publicado: (1997)

Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.
por: Kakolyris, S., et al.
Publicado: (1998)

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity
por: Fielding, Andrew B., et al.
Publicado: (2018)

The Impact of the C-Terminal Region on the Interaction of Topoisomerase II Alpha with Mitotic Chromatin
por: Antoniou-Kourounioti, Melissa, et al.
Publicado: (2019)

Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2018)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
Publicado: (1996)

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
por: Kozuki, Toshiyuki, et al.
Publicado: (2017)

PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis
por: Nielsen, Christian F., et al.
Publicado: (2015)

RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression
por: Ramamoorthy, Mahesh, et al.
Publicado: (2012)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.
por: Kaklamanis, L., et al.
Publicado: (1996)

Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells
por: Wray, Justin, et al.
Publicado: (2009)

Hairpin structures formed by alpha satellite DNA of human centromeres are cleaved by human topoisomerase IIα
por: Jonstrup, Anette Thyssen, et al.
Publicado: (2008)

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors
por: Campbell, Kirsteen J, et al.
Publicado: (2006)

Diversity and Functions of Type II Topoisomerases
por: Sutormin, D. A., et al.
Publicado: (2021)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer
por: Susini, Tommaso, et al.
Publicado: (2014)

Chromatinization Modulates Topoisomerase II Processivity
por: Lee, Jaeyoon, et al.
Publicado: (2023)

Chromatinization modulates topoisomerase II processivity
por: Lee, Jaeyoon, et al.
Publicado: (2023)

Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma
por: Yin, Jie, et al.
Publicado: (2022)

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer
por: Bryant, PE, et al.
Publicado: (2008)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

DNA topoisomerase II alpha promotes the metastatic characteristics of glioma cells by transcriptionally activating β-catenin
por: Liu, Yi, et al.
Publicado: (2022)

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers
por: Chakrabarti, J, et al.
Publicado: (2004)

DNA topoisomerase I and II expression in drug resistantgerm cell tumours
por: Berney, D M, et al.
Publicado: (2002)

Hyperthermia, thermotolerance and topoisomerase II inhibitors.
por: Kampinga, H. H.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_7hnv5vk44cfp36k1dt622h7d2p